MedTrace Logo

Modification of the Local Abnormal Ventricular Activity Only

NCT05331716 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 22

Last updated 2022-10-07

No results posted yet for this study

Summary

Local abnormal ventricular activity (LAVA) is composed of high-frequency, mainly low voltage signals that represent near-field signals from slow-conducting tissue and thus potential VT isthmuses. The identification of LAVA potentials and their modification have usually been a complimentary component of the substrate-based modification of scar related ventricular arrhtyhmias. With better identification through technical solutions and improved algorithms, LAVA modification may be feasible for treatment in therapy refractory VT.

Conditions

  • Ventricular Tachycardia

Interventions

PROCEDURE

Cardiac ablation therapy

In a subset of patients with known therapy refractory arrhythmia sole LAVA modification is fashioned

Sponsors & Collaborators

  • Krankenhaus Landshut Achdorf

    collaborator UNKNOWN

  • University of Kiel

    lead OTHER

Principal Investigators

  • Hendrik Bonnemeier, PhD · University of Kiel - Medical Faculty

  • Stefan Borov, MD · University of Kiel - Medical Faculty

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-01-01
Primary Completion
2021-12-31
Completion
2021-12-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05331716 on ClinicalTrials.gov